A Low-Frequency Variant in MAPK14 Provides Mechanistic Evidence of a Link With Myeloperoxidase: A Prognostic Cardiovascular Risk Marker
Journal of the American Heart Association - United Kingdom
doi 10.1161/jaha.114.001074
Full Text
Open PDFAbstract
Available in full text
Date
August 15, 2014
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)